Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 666

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 666
---

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

### PARENTCO

#### Iris Parent Holding Corp.
By:

/s/ Chris Kim

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

<div align='center'>A-82</div>

TABLE OF CONTENTS

### FOURTH AMENDMENT TO BUSINESS COMBINATION AGREEMENT
This Fourth Amendment to Business Combination Agreement (this “

#### Amendment
”) is entered into as of July 19, 2024, by and among Iris Acquisition Corp, a Delaware corporation (the “

#### SPAC
”), Iris Parent Holding Corp., a Delaware corporation (“

#### ParentCo
”), and Liminatus Pharma, LLC, a Delaware limited liability company (the “

#### Company
”). Each of SPAC, ParentCo, and the Company is also referred to herein as a “

#### Party
” and, collectively, the “

#### Parties
”.

### RECITALS
WHEREAS, the Parties, along with Liminatus Pharma Merger Sub, Inc., a Delaware corporation, and SPAC Merger Sub, Inc., a Delaware corporation, entered into that certain Business Combination Agreement, dated November 30, 2022 (the “

#### BCA
”);

WHEREAS, the Parties previously entered into that certain Amendment to Business Combination Agreement, dated June 1, 2023, to, among other things, extend the Outside Date (as defined in the BCA) to September 11, 2023;

WHEREAS, the Parties previously entered into that certain Second Amendment to Business Combination Agreement, dated August 14, 2023, to among other things, extend the Outside Date (as defined in the BCA) to March 9, 2024;

WHEREAS, the Parties previously entered into that certain Third Amendment to Business Combination Agreement, dated March 9, 2024, to among other things, extend the Outside Date (as defined in the BCA) to July 31, 2024;

WHEREAS, the Parties desire to further amend the BCA to extend the Outside Date; and

WHEREAS, Section 11.1 of the BCA provides that the BCA may only be amended by a written instrument executed by SPAC, ParentCo, and the Company.

### AGREEMENT
NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and in the BCA, for good and valuable consideration, the receipt and suff